SCHEMBL7364308

SCHEMBL7364308

CC(C)Cc1nc(-c2ccncc2)oc1C(=O)C(CCNC(=O)C(C(N)=O)C1CCCCC1)c1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
PPARG P37231 1/20 0.33
PPARA Q07869 1/20 0.33
TP53 P04637 2/20 0.33
POLB P06746 1/20 0.33
NR1H4 Q96RI1 1/20 0.32
EPHX2 P34913 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
TSHR P16473 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
REN P00797 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7363595 0.90 MEN1 (0.31) MEN1KMT2ATP53CYP1A2CYP3A4
SCHEMBL7363588 0.71 ALDH1A1 (0.37) PPARGPPARATP53POLBEPHX2
SCHEMBL6806942 0.71 CTSL (0.43) REN
SCHEMBL7365739 0.66 ERCC1 (0.36) EPHX2SMN1; SMN2
SCHEMBL6806939 0.66 CTSL (0.36) PPARGPPARATP53POLB
SCHEMBL7361089 0.65 IKBKB (0.39) REN
SCHEMBL6797431 0.64 TP53 (0.35) PPARGPPARATP53
SCHEMBL6062675 0.61 CTSS (0.42) CYP3A4SMN1; SMN2
SCHEMBL6807134 0.59 CTSL (0.44) PPARGPPARAPOLB
SCHEMBL6466351 0.59 FAAH (0.38) TP53CYP1A2CYP3A4CYP2D6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1159273-A1 COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CATHEPSIN S BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 2001-12-05 EP disclosed
WO-2000051998-A1 COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CATHEPSIN S BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2000-09-08 WO disclosed